PacBio acquires Omniome in deal worth $800 million, expanding its DNA sequencing capabilities

August 02, 2021 | News Commentary

PacBio specializes in long-read DNA sequencing, which provides insights on genomic variants including immunology, rare diseases, and microbiology. The company seeks to complement its service by integrating Omniome's short-read sequencing...